Twenty-four months follow-up of chronic central serous chorioretinopathy patients after treatment with oral eplerenone or half-dose photodynamic therapy, and crossover treatment: SPECTRA trial report No. 4

被引:0
|
作者
van Rijssen, Th. J. [1 ]
Feenstra, H. M. A. [1 ]
van Dijk, E. H. C. [1 ]
Tsonaka, R. [2 ]
Diederen, R. M. H. [3 ]
Hoyng, C. B. [4 ]
Schlingemann, R. O. [3 ]
Boon, C. J. F. [1 ,3 ]
机构
[1] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands
[3] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:18 / 18
页数:1
相关论文
共 48 条
  • [21] Randomized Clinical Trial to Compare Micropulse Photocoagulation Versus Half-dose Verteporfin Photodynamic Therapy in the Treatment of Central Serous Chorioretinopathy
    Kretz, Florian T. A.
    Beger, Isabell
    Koch, Frank
    Nowomiejska, Katarrzyna
    Auffarth, Gerd U.
    Koss, Michael J.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (08): : 837 - 843
  • [22] Infographic: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial
    Yusuf, Imran H.
    Henein, Christin
    Sivaprasad, Sobha
    EYE, 2024, 38 (SUPPL 2) : 35 - 36
  • [24] Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy
    Fujita, Kyoko
    Shinoda, Kei
    Imamura, Yutaka
    Matsumoto, Celso Soiti
    Oda, Koichi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) : 1 - 7
  • [25] Response to 'Comment on 'Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy"
    Scholz, P.
    Altay, L.
    Fauser, S.
    EYE, 2017, 31 (02) : 346 - 346
  • [26] Risk factors of persistent subretinal fluid after half-dose photodynamic therapy for treatment-naive central serous chorioretinopathy
    Li, Mengyang
    Qu, Jinfeng
    Liang, Zhiqiao
    Tang, Jiyang
    Hu, Jie
    Yao, Yuou
    Jin, Enzhong
    Li, Xiaoxin
    Zhao, Mingwei
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (07) : 2175 - 2182
  • [27] Response to ‘Comment on ‘Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy’’
    P Scholz
    L Altay
    S Fauser
    Eye, 2017, 31 : 346 - 346
  • [28] Reply to Comment on: Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3
    Van Rijssen, Thomas J.
    Van Dijk, Elon H. C.
    Scholz, Paula
    Breukink, Myrte B.
    Blanco-Garavito, Rocio
    Souied, Eric H.
    Keunen, Jan E. E.
    Maclaren, Robert E.
    Querques, Giuseppe
    Fauser, Sascha
    Downes, Susan M.
    Hoyng, Carel B.
    Boon, Camiel J. F.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2020, 212 : 187 - 188
  • [29] Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser
    van Rijssen, Thomas J.
    van Dijk, Elon H. C.
    Scholz, Paula
    Breukink, Myrte B.
    Dijkman, Greet
    Peters, Petrus J. H.
    Tsonaka, Roula
    Keunen, Jan E. E.
    MacLaren, Robert E.
    Hoyng, Carel B.
    Downes, Susan M.
    Fauser, Sascha
    Boon, Camiel J. F.
    ACTA OPHTHALMOLOGICA, 2021, 99 (07) : 805 - 811
  • [30] Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy
    Thomas J. van Rijssen
    Sumit Randhir Singh
    Elon H. C. van Dijk
    Mohammed A. Rasheed
    Kiran Kumar Vupparaboina
    Camiel J. F. Boon
    Jay Chhablani
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 1191 - 1197